ActiveBrain & Nervous System
Mapping the therapeutic potential of targeting endothelial cell dysfunction in Multiple Sclerosis
About this grant
This summary is based on the grant title only — the full abstract was not available.
Research project funded by CSO at University of Glasgow.
View the original record at the funder ↗
Researchers
Hazel Allardyce (EPMC Awardee)
Related Research
Grants with similar aims, by meaning.
Exploiting T cell Annexin-1 as a target for the treatment of multiple sclerosis
Investigating novel therapies to reverse white matter damage and inflammation in Multiple Sclerosis
Identification of novel microglia-derived therapeutic targets for remyelination in multiple sclerosis
Targeting DNA methylation as a novel approach to restore endothelial colony-forming cell angiogenic dysfunction in ischaemic disease
Molecular and Functional Analysis of the relationship between T cell Myelin Epitopes and Disease in Multiple Sclerosis
Original classification
NonePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.Is something wrong? Let us know